Literature DB >> 21866331

Elevated cardiac oxidative stress in newborn rats from mothers treated with atosiban.

Yavuz Simsek1, Onder Celik, Abdullah Karaer, Ercan Yılmaz, Mehmet Gul, Elif Ozerol, Sedat Bilgic, Nilufer Celik.   

Abstract

PURPOSE: The purpose of this study was to evaluate the cardiac and cerebral oxidative stress in the offspings of pregnant rats treated with oxytocin antagonist atosiban.
METHODS: Experimentally naive, adult female Wistar-albino rats (200-250 g) were mated with adult male rats for copulation. After confirming pregnancy, eight gravid rats were then randomly assigned into two equal groups. The animals were treated from days 15 to 20 of gestation. One group acted as a control group, and received intraperitoneal (i.p.) injections of saline in a daily dose volume of 6 mg/kg/day. The second group received 6 mg/kg/day i.p. atosiban. On day 21 of gestation, pups were delivered by cesarean. The heart and brain tissues of the newborn rats were dissected and sent for the measurement of total oxidant status, total antioxitant status and oxidative stress index.
RESULTS: There was no significant difference in birthweight or in the number of pups between two groups. Newborns from atosiban-treated mothers showed significantly increased oxidative stress in the plasma and heart tissue than that of controls which was confirmed by histological examination (P < 0.05). Oxidative stress parameters and histopathological results of the brain tissues of newborns were similar between two groups (P > 0.05).
CONCLUSION: Oxytocin receptor blockage for the treatment of premature delivery may be associated with increased fetal morbidity and mortality secondary to the elevated oxidative stress in the heart of the newborns.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21866331     DOI: 10.1007/s00404-011-2069-5

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  8 in total

1.  DNA damage after chronic oxytocin administration in rats: a safety yellow light?

Authors:  Daniela D Leffa; Francine Daumann; Adriani P Damiani; Arlindo C Afonso; Maria A Santos; Thayara H Pedro; Renan P Souza; Vanessa M Andrade
Journal:  Metab Brain Dis       Date:  2016-08-03       Impact factor: 3.584

Review 2.  Mitochondria, Oxytocin, and Vasopressin: Unfolding the Inflammatory Protein Response.

Authors:  Evan A Bordt; Caroline J Smith; Tyler G Demarest; Staci D Bilbo; Marcy A Kingsbury
Journal:  Neurotox Res       Date:  2018-09-27       Impact factor: 3.911

3.  Hypothalamic oxytocin mediates social buffering of the stress response.

Authors:  Adam S Smith; Zuoxin Wang
Journal:  Biol Psychiatry       Date:  2013-09-28       Impact factor: 13.382

4.  Oxytocin effects on experimental skin wound healing.

Authors:  Heiko Sorg; Eberhard Grambow; Erik Eckl; Brigitte Vollmar
Journal:  Innov Surg Sci       Date:  2017-08-08

5.  Effects of PM2.5 and gases exposure during prenatal and early-life on autism-like phenotypes in male rat offspring.

Authors:  Baharan Emam; Abbas Shahsavani; Fariba Khodagholi; Saeed Motesaddi Zarandi; Philip K Hopke; Mostafa Hadei; Hamidreza Behbahani; Maryam Yarahmadi
Journal:  Part Fibre Toxicol       Date:  2020-01-29       Impact factor: 9.400

Review 6.  Love and longevity: A Social Dependency Hypothesis.

Authors:  Alexander J Horn; C Sue Carter
Journal:  Compr Psychoneuroendocrinol       Date:  2021-09-30

7.  Oxytocin and Vasopressin, and the GABA Developmental Shift During Labor and Birth: Friends or Foes?

Authors:  Yehezkel Ben-Ari
Journal:  Front Cell Neurosci       Date:  2018-08-21       Impact factor: 5.505

Review 8.  Is Oxytocin "Nature's Medicine"?

Authors:  C Sue Carter; William M Kenkel; Evan L MacLean; Steven R Wilson; Allison M Perkeybile; Jason R Yee; Craig F Ferris; Hossein P Nazarloo; Stephen W Porges; John M Davis; Jessica J Connelly; Marcy A Kingsbury
Journal:  Pharmacol Rev       Date:  2020-10       Impact factor: 25.468

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.